EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch

Nicole J van Steijn, Isabel S Blommestijn, Sebastiaan Blok, Shari Pepplinkhuizen, G Aernout Somsen, Reinoud E Knops, Laura Breukel, Jan G P Tijssen, Igor I Tulevski, Philip M Croon, Michiel M Winter

JACC · 2026-04 · 87 (14) · 1714-1728

DOI: 10.1016/j.jacc.2025.11.032 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC, 2026-04. Verfasst von Nicole J van Steijn und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Wearable Electronic Devices. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: U.S. Food and Drug Administration, Apple.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atrial fibrillation (AF), the most common cardiac arrhythmia, is a major cause of stroke and often remains undiagnosed due to its paroxysmal and frequently asymptomatic nature. Wearables provide a scalable, noninvasive screening tool. OBJECTIVES: This trial evaluated new onset AF detection in patients at elevated stroke risk using remote smartwatch-based screening. METHODS: This prospective multicenter randomized controlled trial included patients ≥65 years with elevated stroke risk (CHA2DS2-VASc ≥2 men, ≥3 women) from 2 secondary care centers in the Netherlands. Patients were randomized to 6-month (180-day) monitoring with a smartwatch with photoplethysmography and single-lead electrocardiogram (ECG) functions, or standard care. ECGs were reviewed remotely by an independent eHealth team within 24 hours. The primary outcome was new onset AF, defined as a confirmed episode lasting ≥30 seconds on single-lead ECG or standard ECG methods. RESULTS: Between November 2022 and December 2023, 437 patients were randomized (219 intervention, 218 control); the median age was 75 years, 46.7% were female and the median CHA2DS2-VASc score was 3.0. New onset AF occurred in 21 (9.6%) patients of the intervention group and 5 (2.3%) patients of the control group (risk difference: 7.3 percentage points; 95% CI: 2.9-11.7 percentage points; P = 0.001; HR: 4.40; 95% CI: 1.66-11.66). Several asymptomatic AF episodes were detected only in the intervention group, while paroxysmal AF occurred in both groups. CONCLUSIONS: This randomized controlled trial provides evidence that 6-month smartwatch-based AF screening enhances the detection rate of new onset AF compared with standard care in patients at elevated stroke risk. (Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable [Apple Watch] [EQUAL]; NCT05686330).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationWearable Electronic DevicesHumansFemaleAgedProspective StudiesMaleElectrocardiographyRemote Patient MonitoringDigital HealthNetherlandsAged, 80 and overStrokePhotoplethysmography

Stichwörter der Autor:innen

atrial fibrillationdigital healthrandomized controlled trialremote monitoringwearable technology

Autor:innen und Institutionen

  • Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; Cardiology Centers of the Netherlands, Utrecht, the Netherlands. Ele…
  • Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; Cardiology Centers of the Netherlands, Utrecht, the Netherlands.
  • Cardiology Centers of the Netherlands, Utrecht, the Netherlands.
  • Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Cardiology, Spaarne Gasthuis, Haarlem, the Netherlands.
  • Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; Section of cardiovascular Medicine, Department of Internal Medicine,…

Förderung

  • U.S. Food and Drug Administration
  • Apple

Zitieren

APA

van Steijn, N. J., Blommestijn, I. S., Blok, S., Pepplinkhuizen, S., Somsen, G. A., Knops, R. E., Breukel, L., Tijssen, J. G. P., Tulevski, I. I., Croon, P. M., & Winter, M. M. (2026). Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch. JACC, 87(14), 1714-1728. https://doi.org/10.1016/j.jacc.2025.11.032

Vancouver

van Steijn NJ, Blommestijn IS, Blok S, Pepplinkhuizen S, Somsen GA, Knops RE, et al. Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch. JACC. 2026;87(14):1714-1728. doi:10.1016/j.jacc.2025.11.032

BibTeX
@article{vanSteijn2026,
  author = {van Steijn, Nicole J and Blommestijn, Isabel S and Blok, Sebastiaan and Pepplinkhuizen, Shari and Somsen, G Aernout and Knops, Reinoud E and Breukel, Laura and Tijssen, Jan G P and Tulevski, Igor I and Croon, Philip M and Winter, Michiel M},
  title = {Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {14},
  pages = {1714--1728},
  doi = {10.1016/j.jacc.2025.11.032}
}
Kostenlos starten →